Literature DB >> 18584206

Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones.

Nobuyuki Miyazaki1, Terumasa Nakatsuka, Daisuke Takeda, Kazuhiro Nohda, Kazuhide Inoue, Munehito Yoshida.   

Abstract

Although adenosine is an important neuromodulator, its role in modulating motor functions at the level of the spinal cord is poorly understood. In the present study, we investigated the effects of adenosine on excitatory synaptic transmission and neuronal death induced by experimental ischaemia by using whole-cell patch-clamp recordings from lamina IX neurones in spinal cord slices. Adenosine significantly decreased the frequency of miniature excitatory postsynaptic currents (mEPSCs) in almost all neurones examined that could be mimicked by an A(1) receptor agonist, N (6)-cyclopentyladenosine (CPA), and inhibited by an A(1) receptor antagonist, 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX). Interestingly, adenosine increased mEPSC frequency in the presence of DPCPX in a subpopulation of neurones. In these neurones, an A(2A) receptor agonist, 2-[4-(2-carbonylethyl)-phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680), increased mEPSC frequency. Adenosine also induced an outward current that was blocked by the addition of Cs(+) and tetraethylammonium into the patch-pipette solution and inhibited in the presence of Ba(2+). The adenosine-induced outward current was mimicked by CPA, but not CGS21680, and inhibited by DPCPX. Moreover, superfusing with ischaemia simulating medium (ISM) generated an agonal inward current in all of the neurones tested. The latencies of the inward currents induced by ISM were significantly prolonged by adenosine or CPA, but not by CGS21680. These results suggest that adenosine receptors are functionally expressed in both the pre- and postsynaptic sites of lamina IX neurones and that their activation may exert multiple effects on motor function. Moreover, this study has provided a cellular basis for an involvement of A(1) receptors in the neuroprotective actions of adenosine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584206     DOI: 10.1007/s00424-008-0542-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  52 in total

Review 1.  Acute spinal cord injury: pharmacotherapy and drug development perspectives.

Authors:  A R Blight; M P Zimber
Journal:  Curr Opin Investig Drugs       Date:  2001-06

Review 2.  Role of adenosine as a modulator of synaptic activity in the central nervous system.

Authors:  J M Brundege; T V Dunwiddie
Journal:  Adv Pharmacol       Date:  1997

3.  Identification of A1 and A2 adenosine receptors in the rat spinal cord.

Authors:  J I Choca; H K Proudfit; R D Green
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

4.  Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.

Authors:  S Latini; F Bordoni; F Pedata; R Corradetti
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists.

Authors:  Y W Lee; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

6.  Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus.

Authors:  R A Cunha; E Milusheva; E S Vizi; J A Ribeiro; A M Sebastião
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

7.  Adenosine acting at an A1 receptor decreases N-type calcium current in mouse motoneurons.

Authors:  M Mynlieff; K G Beam
Journal:  J Neurosci       Date:  1994-06       Impact factor: 6.167

Review 8.  Adenosine receptor interactions and anxiolytics.

Authors:  R F Bruns; J J Katims; Z Annau; S H Snyder; J W Daly
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

9.  Adenosine inhibition of synaptic transmission in the substantia gelatinosa.

Authors:  J Li; E R Perl
Journal:  J Neurophysiol       Date:  1994-10       Impact factor: 2.714

10.  Hypothermia suppresses excitatory synaptic transmission and neuronal death induced by experimental ischemia in spinal ventral horn neurons.

Authors:  Hideto Nishi; Terumasa Nakatsuka; Daisuke Takeda; Nobuyuki Miyazaki; Junya Sakanaka; Hiroshi Yamada; Munehito Yoshida
Journal:  Spine (Phila Pa 1976)       Date:  2007-12-01       Impact factor: 3.468

View more
  8 in total

1.  Hydrogen peroxide modulates synaptic transmission in ventral horn neurons of the rat spinal cord.

Authors:  Masayuki Ohashi; Toru Hirano; Kei Watanabe; Keiichi Katsumi; Nobuko Ohashi; Hiroshi Baba; Naoto Endo; Tatsuro Kohno
Journal:  J Physiol       Date:  2015-12-07       Impact factor: 5.182

2.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 3.  Targeting of adenosine receptors in ischemia-reperfusion injury.

Authors:  Victor E Laubach; Brent A French; Mark D Okusa
Journal:  Expert Opin Ther Targets       Date:  2010-11-29       Impact factor: 6.902

4.  Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.

Authors:  Seng Kah Ng; Haruki Higashimori; Michaela Tolman; Yongjie Yang
Journal:  Exp Neurol       Date:  2015-03-13       Impact factor: 5.330

5.  The mu opioid receptor activation does not affect ischemia-induced agonal currents in rat spinal ventral horn.

Authors:  Hiroyuki Honda; Hiroshi Baba; Tatsuro Kohno
Journal:  J Anesth       Date:  2014-04-19       Impact factor: 2.078

6.  Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects.

Authors:  Irene Paterniti; Alessia Melani; Sara Cipriani; Francesca Corti; Tommaso Mello; Emanuela Mazzon; Emanuela Esposito; Placido Bramanti; Salvatore Cuzzocrea; Felicita Pedata
Journal:  J Neuroinflammation       Date:  2011-04-12       Impact factor: 8.322

7.  In vivo patch-clamp analysis of the antinociceptive actions of TRPA1 activation in the spinal dorsal horn.

Authors:  Manabu Yamanaka; Wataru Taniguchi; Naoko Nishio; Hiroshi Hashizume; Hiroshi Yamada; Munehito Yoshida; Terumasa Nakatsuka
Journal:  Mol Pain       Date:  2015-04-21       Impact factor: 3.395

8.  Adenosine-mediated modulation of ventral horn interneurons and spinal motoneurons in neonatal mice.

Authors:  Emily C Witts; Filipe Nascimento; Gareth B Miles
Journal:  J Neurophysiol       Date:  2015-08-26       Impact factor: 2.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.